Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Guardant Health Inc (GH)

Guardant Health Inc (GH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 11,098,292
  • Shares Outstanding, K 131,170
  • Annual Sales, $ 982,020 K
  • Annual Income, $ -416,280 K
  • EBIT $ -437 M
  • EBITDA $ -403 M
  • 60-Month Beta 1.67
  • Price/Sales 11.77
  • Price/Cash Flow N/A
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 69.10% (-2.22%)
  • Historical Volatility 42.79%
  • IV Percentile 82%
  • IV Rank 38.62%
  • IV High 103.43% on 04/04/25
  • IV Low 47.50% on 08/13/25
  • Expected Move (DTE 17) 10.03 (11.64%)
  • Put/Call Vol Ratio 0.91
  • Today's Volume 258
  • Volume Avg (30-Day) 702
  • Put/Call OI Ratio 1.20
  • Today's Open Interest 23,234
  • Open Int (30-Day) 21,690
  • Expected Range 76.17 to 96.23

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 24 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate -0.75
  • Number of Estimates 4
  • High Estimate -0.68
  • Low Estimate -0.84
  • Prior Year -0.77
  • Growth Rate Est. (year over year) +2.60%

Price Performance

See More
Period Period Low Period High Performance
1-Month
82.26 +4.79%
on 03/12/26
96.52 -10.69%
on 03/05/26
-7.70 (-8.20%)
since 02/27/26
3-Month
82.26 +4.79%
on 03/12/26
120.74 -28.61%
on 01/22/26
-16.78 (-16.29%)
since 12/26/25
52-Week
36.36 +137.07%
on 05/23/25
120.74 -28.61%
on 01/22/26
+43.06 (+99.81%)
since 03/28/25

Most Recent Stories

More News
Guardant Health’s InfinityAI Real-World Evidence Supports Approval of ENHERTU® for Previously Treated Patients with HER2-Positive Metastatic Solid Tumors in Japan

This milestone underscores the power of Guardant Health’s InfinityAI platform and real-world data to enable innovative evidence generation in rare biomarker-defined populations

GH : 86.20 (+1.88%)
Why Guardant Health (GH) Stock Is Falling Today

Why Guardant Health (GH) Stock Is Falling Today

GH : 86.20 (+1.88%)
3 Growth Stocks We Think Twice About

3 Growth Stocks We Think Twice About

GH : 86.20 (+1.88%)
ROOT : 43.29 (-1.39%)
RUN : 12.14 (-3.65%)
Verana Health and Guardant Health Partner to Advance Precision Medicine with Real-World Data

Combination of high quality, variable-rich, curated EHR data with genomics enhances understanding of the patient journey and aids in therapy development  

GH : 86.20 (+1.88%)
3 Reasons to Avoid GH and 1 Stock to Buy Instead

3 Reasons to Avoid GH and 1 Stock to Buy Instead

GH : 86.20 (+1.88%)
Guardant Health to Present 28 Abstracts Highlighting Advances in Tumor Typing, Therapy Selection and Expanded Utility of Multiomic Tissue and Liquid Biopsy Testing at AACR 2026

Guardant Reveal demonstrates expanded utility in identifying new, primary cancers during minimal residual disease (MRD) monitoring Studies show strong...

GH : 86.20 (+1.88%)
Guardant Health Launches Shield Multi-Cancer Detection (MCD) Test in Multiple Markets in Asia with Manulife Partnership

Partnership marks the first introduction of Shield ™ multi-cancer detection test in the region with availability across Hong Kong, Singapore and the Philippines ...

GH : 86.20 (+1.88%)
New Guardant Health/Harris Poll Survey Shows 92% of All Eligible Americans Believe Colorectal Cancer Blood Tests Should be Accessible and Covered Similar to Medicare

Survey highlights barriers to colorectal cancer screening for adults 45 and over Overwhelming majority (92%) of Americans ages 45 and over believe blood-based...

GH : 86.20 (+1.88%)
Guardant Health’s Shield Blood-based Screening Test for Colorectal Cancer Now Accessible Through National Test Ordering and Collection Network of Quest Diagnostics

Strategic collaboration to enable streamlined and accelerated access to Shield blood-based colorectal cancer screening test across Quest’s vast network ...

GH : 86.20 (+1.88%)
1 Russell 2000 Stock on Our Watchlist and 2 We Question

1 Russell 2000 Stock on Our Watchlist and 2 We Question

GH : 86.20 (+1.88%)
SRCE : 68.57 (+0.56%)
GBTG : 5.40 (+1.31%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Guardant Health Inc. is a precision oncology company. It focuses on conquer cancer through use of proprietary blood tests, vast data sets and advanced analytics. The company's Guardant Health Oncology Platform is designed for clinical development, regulatory and reimbursement to drive commercial adoption,...

See More

Key Turning Points

3rd Resistance Point 90.35
2nd Resistance Point 88.88
1st Resistance Point 87.54
Last Price 86.20
1st Support Level 84.73
2nd Support Level 83.26
3rd Support Level 81.92

See More

52-Week High 120.74
Fibonacci 61.8% 88.51
Last Price 86.20
Fibonacci 50% 78.55
Fibonacci 38.2% 68.59
52-Week Low 36.36

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.